Literature DB >> 15370162

The relationship between smoking cessation and mouth ulcers.

Hayden McRobbie1, Peter Hajek, Fiona Gillison.   

Abstract

Patients who stop smoking often complain of aphthous (mouth) ulcers. This symptom is sometimes attributed to the use of smoking cessation medications, but little is known about it. We investigated the incidence, severity, and time course of mouth ulcers in abstaining smokers and the effect of different smoking cessation medications on the symptom. The sample consisted of 1234 smokers who sought treatment at a large smoking cessation clinic, maintained at least 1 week of continuous biochemically validated abstinence, and provided usable data. Participants assessed their mouth ulcers by rating a mouth ulcer item added to the Mood and Physical Symptoms Scale. Subjects made ratings weekly on three occasions while still smoking and over 4 weeks following smoking cessation. After stopping smoking, some 40% of patients developed mouth ulcers, mostly in the first 2 weeks. The problem was generally mild, but 8% reported severe ulceration. The ulcers resolved within 4 weeks in 60% of patients affected. The ulcer ratings in patients using oral nicotine replacement products were higher than in those using patch, nasal spray or bupropion in the first week of abstinence but not afterward. Mouth ulcers were more prevalent in more dependent smokers, and the occurrence of ulcers correlated with other tobacco withdrawal symptoms. Our results confirm that mouth ulcers are a common result of stopping smoking, affecting two in five quitters. Patients should be reassured that the lesions are a result of stopping smoking and not a side-effect of smoking cessation medication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370162     DOI: 10.1080/14622200410001734012

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  11 in total

1.  Recurrent aphthous ulcers among tobacco users- hospital based study.

Authors:  Shamaz Mohamed; Chandrashekar Janakiram
Journal:  J Clin Diagn Res       Date:  2014-11-20

Review 2.  Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.

Authors:  J Taylor Hays; Jon O Ebbert
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

3.  Does smoking really protect from recurrent aphthous stomatitis?

Authors:  Faleh A Sawair
Journal:  Ther Clin Risk Manag       Date:  2010-11-22       Impact factor: 2.423

Review 4.  Update on medicines for smoking cessation.

Authors:  Mike McDonough
Journal:  Aust Prescr       Date:  2015-08-03

5.  Interventions for tobacco cessation delivered by dental professionals.

Authors:  Richard Holliday; Bosun Hong; Elaine McColl; Jonathan Livingstone-Banks; Philip M Preshaw
Journal:  Cochrane Database Syst Rev       Date:  2021-02-19

6.  The recurrent aphthous stomatitis frequency in the smoking cessation people.

Authors:  Kamile Marakoğlu; Recep Erol Sezer; Hülya Cakmak Toker; Ismail Marakoğlu
Journal:  Clin Oral Investig       Date:  2007-02-02       Impact factor: 3.606

7.  Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.

Authors:  Edward J Mills; Ping Wu; Ian Lockhart; Kumanan Wilson; Jon O Ebbert
Journal:  Tob Induc Dis       Date:  2010-07-13       Impact factor: 2.600

Review 8.  Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners.

Authors:  Bassel Tarakji; Giath Gazal; Sadeq Ali Al-Maweri; Saleh Nasser Azzeghaiby; Nader Alaizari
Journal:  J Int Oral Health       Date:  2015-05

9.  Prevalence of recurrent aphthous ulceration experience in patients attending Piramird dental speciality in Sulaimani City.

Authors:  Mustafa J Abdullah
Journal:  J Clin Exp Dent       Date:  2013-04-01

10.  Symptoms in smokers trying to quit.

Authors:  Tanja Tomson; Mats Toftgård; Hans Gilljam; Asgeir R Helgason
Journal:  Tob Induc Dis       Date:  2006-08-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.